AKUMS DRUGS & PHARMACEUTICALS
|
The Current P/B Ratio of AKUMS DRUGS & PHARMACEUTICALS is 11.67.
Share Price | ₹526.0 | Apr 29,2025 |
Market Cap | ₹8,279.2 Cr | |
Book Value | ₹709.5 Cr | Mar2024 - Consolidated Results |
Price/Book | 11.67x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of AKUMS DRUGS & PHARMACEUTICALS
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹8,279.2 Cr] as on Apr 29,2025
(/) Book Value [ ₹709.5 Cr] based on Mar2024 - Consolidated Results
(=) P/B Ratio [ 11.67x ]
Thus, for AKUMS DRUGS & PHARMACEUTICALS , the investors are currently willing to pay '11.67 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of AKUMS DRUGS & PHARMACEUTICALS !
The chart below summarizes the trend in P/B Ratio of AKUMS DRUGS & PHARMACEUTICALS over the last five years.
Historical PB (Price/Book ) ratio chart of AKUMS DRUGS & PHARMACEUTICALS
PB Ratio Performance Analysis for AKUMS DRUGS & PHARMACEUTICALS
- AKUMS DRUGS & PHARMACEUTICALS 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.00x.
- AKUMS DRUGS & PHARMACEUTICALS 's operated at median p/b ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, AKUMS DRUGS & PHARMACEUTICALS 's p/b ratio peaked in Mar2024 at 0x.
- AKUMS DRUGS & PHARMACEUTICALS 's p/b ratio hit its five-year low in Mar2024 of 0x.
How does AKUMS DRUGS & PHARMACEUTICALS 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
AKUMS DRUGS & PHARMACEUTICALS | 709.50 | 11.67 | 8,279.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.80 | 433,032.0 |
DIVIS LABORATORIES LTD | 13,571.00 | 11.96 | 162,252.0 |
CIPLA LTD | 26,619.90 | 4.68 | 124,457.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 16.40 | 112,425.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 3.49 | 98,152.8 |
MANKIND PHARMA LTD | 9,339.84 | 11.30 | 105,505.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 4.51 | 89,348.5 |
LUPIN LTD | 14,175.80 | 6.66 | 94,400.9 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.35 | 70,259.6 |
ABBOTT INDIA LTD | 3,658.73 | 17.48 | 63,948.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs AKUMS DRUGS & PHARMACEUTICALS 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.35x |
Max industry PB | 17.48x |
Median industry PB | 6.80x |
Average industry PB | 8.84x |
You may also like the below Video Courses